搜索临床试验以:Envarsus
总计66个结果
-
University Health Network, TorontoPaladin Labs Inc.尚未招聘肝移植排斥反应 | 免疫系统抑制
-
University of British ColumbiaPaladin Labs Inc.招聘中
-
Vanderbilt University Medical CenterVeloxis Pharmaceuticals招聘中
-
University of Southern CaliforniaVeloxis Pharmaceuticals招聘中
-
Beth Israel Deaconess Medical CenterVeloxis Pharmaceuticals尚未招聘服药依从性 | 肾移植
-
Imperial College London招聘中
-
Medical University of Warsaw招聘中
-
California Institute of Renal ResearchUniversity of California, San Diego; Balboa Institute of Transplantation招聘中
-
Medical University of South CarolinaVeloxis Pharmaceuticals完全的
-
Sentara Norfolk General HospitalVeloxis Pharmaceuticals完全的
-
Edward GeisslerExcelya; Chiesi Pharmaceuticals GmbH主动,不招人
-
Nantes University HospitalChiesi Farmaceutici S.p.A.完全的
-
University of California, DavisVeloxis Pharmaceuticals完全的
-
University of WashingtonNational Cancer Institute (NCI)终止转移性前列腺癌 | 前列腺癌 | IV 期前列腺癌 AJCC v8 | 骨转移性恶性肿瘤 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 前列腺小细胞神经内分泌癌 | 去势敏感性前列腺癌美国
-
University of NebraskaNational Cancer Institute (NCI)完全的淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 多发性骨髓瘤和浆细胞肿瘤 | 骨髓增生异常/骨髓增生性疾病 | 移植物抗宿主病 | 继发性骨髓纤维化美国
-
Cedars-Sinai Medical CenterVeloxis Pharmaceuticals主动,不招人
-
University of Wisconsin, MadisonVeloxis Pharmaceuticals完全的
-
University of California, Los AngelesVeloxis Pharmaceuticals主动,不招人
-
University of Kansas Medical CenterVeloxis Pharmaceuticals完全的
-
Columbia UniversityVeloxis Pharmaceuticals主动,不招人
-
The Methodist Hospital Research InstituteVeloxis Pharmaceuticals撤销肾移植急性排斥反应 | 肾脏疾病,终末期 | 供体特异性抗体
-
University of Illinois at ChicagoVeloxis Pharmaceuticals完全的